期刊文献+

红芪多糖对膀胱癌大鼠抗肿瘤作用的实验研究 被引量:18

Experimental Research on the Anti-tumor Effect of Hedysamn Polysaccharide in Rats with Bladder Cancer
下载PDF
导出
摘要 目的探讨红芪多糖对膀胱癌大鼠抗肿瘤作用的相关机制研究。方法采用酶联免疫吸附试验法和RT-PCR法,观察不同药物剂量的红芪多糖对膀胱癌大鼠模型血清中VEGF、IL-2和膀胱组织中AQP1和AQP3表达变化的影响。结果红芪多糖对膀胱癌大鼠肿瘤抑制效果以中剂量为佳,其可以提高血清中IL-2含量,减少VEGF含量水平,同时下调AQP1和AQP3基因表达。结论红芪多糖对膀胱癌大鼠的肿瘤生长确实有一定的抑制作用,其机制为增强机体免疫功能,同时其可能通过调节膀胱癌组织AQP1和AQP3,而产生利水渗湿功效,从而达到抑制膀胱癌效果。 Objective To investigate the mechanism of the anti-tumor effect of hedysamn polysaccharide in rats with bladder cancer. Methods ELISA and RT-PCR were used to observe the effect of hedysamn polysaecharide in different dose on the expression ofVEGF, IL-2, AQP1 and AQP3 in rats with bladder cancer. Results Hedysamn polysaccharide in the middle dose has the best effect on bladder cancer rats though increasing the content of IL-2 and reducing the expression ofVEGF, AQP1 and AQP3. Conclusion Hedysamn polysaccharide has a great effect on antitumor in rats with bladder cancer.The mechanism maybe boost immune function, regulate the expression of AQP1 and AQP3 to suppress the growth of cancer cell.
出处 《国外医药(抗生素分册)》 CAS 2015年第1期27-28,共2页 World Notes on Antibiotics
关键词 红芪多糖 膀胱癌 IL-2 VEGF AQP1 AQP3 hedysamn polysaccharide bladder cancer IL-2 VEGF AQPI AQP3
  • 相关文献

参考文献5

二级参考文献27

  • 1许利民,洪淋,张书模.恶性血液病患者红细胞免疫功能的变化及其意义[J].第三军医大学学报,1996,18(2):122-124. 被引量:2
  • 2陆德源,马宝骊.现代免疫学[M].上海:上海科学技术出版社,1993,58~7 3 被引量:1
  • 3Rubin LA,Rurman CC,Fritz ME,et al.Soluble interleukin 2 receptor are r eleased from activated human lymphod cells in vitro[J].Immurol,1985,135:31 72 被引量:1
  • 4BLOOM BR, SALGAME P, DIAMOND B. Revisiting and revising suppressor T cells[J]. Immunol Today, 1992, 13:131~136. 被引量:1
  • 5BERGHELLA AM, PELLEGRINI P, BEATO TD, et al. The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH 1 to TH 2 and back[J]. cCancer Immunol Immunother, 1998, 45:241~249. 被引量:1
  • 6NIEHANS GA, CHERWITZ DL, STALEY NA, et al. Human carcinomas variably express the complement inhibitory proteins CD 49(Membrane), CD55(Decay accelerating factor), and CD59(Protectin)[J]. Am J Pathol, 1996, 149(1):129. 被引量:1
  • 7HERNDERG M, MAHONEN T, PGRHONEN S. Can the CD4+/CD8+ ratio predict the outcome of interferon-alpha therapy for renal cell carcinoma[J]. Annals Oncology, 1997, 8(1): 71. 被引量:1
  • 8Takata K,Matauzaki T,Tajika Y.Aquaporins:water channel protein of the cell membrane[J].Prog Histochem Cytochem,2004,39:1-83. 被引量:1
  • 9Verkman A.Roles of aquaporins in kidney revealed by transgenic mice[J].Semin Nephrol,2006,26 (3):200-208. 被引量:1
  • 10Stephen G,Williams P.Molecular pathways in bladder cancer[J].Urol Res,2004,32:373-385. 被引量:1

共引文献22

同被引文献363

引证文献18

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部